Creatine Supplementation Does Not Cause Kidney Injury in Healthy Individuals
Creatine supplementation at 3-5 g per day is safe and does not cause kidney injury or clinically significant side effects in individuals with normal kidney function. 1, 2, 3
Key Evidence on Renal Safety
The most recent and highest quality evidence demonstrates that creatine supplementation does not impair kidney function:
The 2026 meta-analysis of 26 RCTs (1,036 participants) found that while serum creatinine increases by 0.14 mg/dL with creatine supplementation, there were no changes in GFR when measured by the gold-standard Cr-EDTA method (MD 5.89 mL/min, P=0.06), and no changes in serum urea, albuminuria, or proteinuria 2. This definitively shows the creatinine elevation reflects altered creatinine metabolism, not kidney damage.
A 2020 double-blind RCT using sensitive kidney injury biomarkers (KIM-1 and MCP-1) found no difference between placebo, 3 g/day, and 5 g/day creatine groups after 35 days 1. These novel biomarkers detect actual kidney injury before traditional markers change, providing strong evidence of safety.
The 2019 meta-analysis similarly concluded that creatine supplementation does not induce renal damage at studied doses and durations 4.
Understanding the Creatinine Paradox
The increase in serum creatinine with creatine supplementation is a measurement artifact, not kidney injury:
- Creatine is spontaneously converted to creatinine in muscle tissue at a constant rate of approximately 2% per day
- Higher creatine stores naturally produce more creatinine as a metabolic byproduct
- This explains why creatinine-based eGFR calculations show falsely reduced values (MD -10.75 mL/min) 2, while direct GFR measurement by Cr-EDTA shows no change 2
- A case study in a patient with a solitary kidney demonstrated this exact phenomenon: serum creatinine rose from 1.03 to 1.27 mg/dL with 20 g/day creatine, but Cr-EDTA clearance remained unchanged (81.6 vs 82.0 mL/min/1.73m²) 5
Clinical Implications and Caveats
Important considerations for clinical practice:
Avoid misdiagnosing AKI: When evaluating patients on creatine, recognize that elevated creatinine does not indicate kidney injury if other markers (urea, proteinuria, albuminuria, direct GFR measurement) remain normal 2, 3
Timing of kidney function assessment: If accurate GFR estimation is needed (e.g., for living kidney donor evaluation), discontinue creatine supplementation beforehand to avoid misclassification 5
Patients with pre-existing kidney disease: While evidence in healthy individuals is robust, data in CKD patients remains limited. The 2018 review recommends avoiding creatine in those with pre-existing kidney disease or risk factors for kidney dysfunction until more evidence emerges 6
Duration of safety data: Studies range from 5 days to 5 years of supplementation at doses of 3-30 g/day, all showing safety 6. The longest-term data supports continued safety.
Guideline Perspective
The 2020 American Journal of Kidney Diseases guideline on dietary supplements in living kidney donors specifically addresses creatine, noting that while it doesn't compromise GFR, it affects the ability to accurately estimate it 5. This guideline recommends discouraging dietary supplements in donor populations due to potential confounding of kidney function assessment, but this is a measurement concern, not a toxicity concern.
The evidence overwhelmingly supports that creatine supplementation at standard doses (3-5 g/day) does not cause kidney injury, side effects, or functional impairment in individuals with normal baseline kidney function. The observed creatinine elevation is a predictable metabolic consequence of increased creatine stores, not nephrotoxicity.